Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial.
Jian Yang,Lifang Yang,Shiqiang Yu,Jincheng Liu,Jian Zuo,Wensheng Chen,Weixun Duan,Qijun Zheng,Xuezeng Xu,Jun Li,Jun Zhang,Jian Xu,Lijun Sun,Xiuling Yang,Lize Xiong,Dinghua Yi,Lei Wang,Qingchun Liu,Shuping Ge,Jun Ren
DOI: https://doi.org/10.1016/j.jacc.2014.01.008
IF: 24
2014-01-01
Journal of the American College of Cardiology
Abstract:OBJECTIVES:The objective of this study was to evaluate the safety and efficacy of the surgical versus transcatheter approach to correct perimembranous ventricular septal defects (pmVSDs) in a prospective, randomized, controlled clinical trial.
BACKGROUND:pmVSD is a common congenital heart disease in children. Surgical closure of pmVSD is a well-established therapy but requires open-heart surgery with cardiopulmonary bypass. Although the transcatheter approach is associated with significant incidence of complete atrioventricular block, it may provide a less invasive alternative. Critical comparison of the safety and efficacy of the 2 interventions necessitates a prospective, randomized, controlled trial.
METHODS:Between January 2009 and July 2010, 229 children with pmVSD were randomly assigned to surgical or transcatheter intervention. Clinical, laboratory, procedural, and follow-up data over a 2-year period were compared.
RESULTS:Neither group had mortality or major complications. However, statistical analysis of the 2 groups demonstrated significant differences (p < 0.001) in minor adverse events (32 vs. 7), quantity of blood transfused, duration of the procedure, median hospital stay, median intensive care unit stay, median hospitalization cost, and median blood loss. During a median follow-up of 2 years, the left ventricular end-diastolic dimension of both groups returned to normal and there was no difference in closure rate, adverse events, and complications between groups.
CONCLUSIONS:Transcatheter device closure and surgical repair are effective interventions with excellent midterm results for treating pmVSD in children. Transcatheter device closure has a lower incidence of myocardial injury, less blood transfused, faster recovery, shorter hospital stay, and lower medical expenses. (Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects; NCT00890799).